Showing 12,541 - 12,560 results of 121,998 for search '(( 2 d decrease ) OR ( 5 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.14s Refine Results
  1. 12541
  2. 12542

    Supplemental Fig. S2 from RNF6 Inhibits Lung Adenocarcinoma Cell Proliferation by Promoting Cyclin D2 Degradation by Yuening Sun (21232876)

    Published 2025
    “…<p>Supplemental Fig. S2. RNF6 decreases the half-life of CCND2. (A) A549 and NCI-H1299 cells were transfected a Flag-RNF6 plasmid for 48 hrs, followed by treatment with MG132 for 8 hrs and IP/IB assays. …”
  3. 12543

    Annexin A5 Promoter Haplotype M2 Is Not a Risk Factor for Recurrent Pregnancy Loss in Northern Europe by Liina Nagirnaja (718847)

    Published 2015
    “…<div><p>Introduction</p><p>Annexin A5 is an essential component of placental integrity that may potentially mediate susceptibility to phenotypes of compromised pregnancy. …”
  4. 12544

    Image2_Case report: Double filtration plasmapheresis (DFPP) for severe rhesus-D alloimmunization in two pregnant patients.tiff by Yuling Liang (4636447)

    Published 2023
    “…The favorable results of the two patients indicate that DFPP may be an effective and safe treatment modality for RhD immunity in pregnant women. …”
  5. 12545

    image_2_Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis.jpeg by Gabriel Mizraji (5139530)

    Published 2018
    “…Investigations of the immune mechanism of RvD2 actions reveal that 6 weeks after infection, the gingiva of RvD2-treated mice exhibit decreased CD4<sup>+</sup> T-cells as well as lower RANKL expression levels and higher osteoprotegerin expression levels. …”
  6. 12546

    Time course of the variances (<i>V</i><sub><i>ip</i></sub>, <i>V</i><sub><i>g</i></sub>) after switching interaction strength. by Naoto Nishiura (11668953)

    Published 2021
    “…The two variances of the non-target output genes decrease, while <i>V</i><sub><i>g</i></sub> < <i>V</i><sub><i>ip</i></sub> is maintained throughout the evolutionary course (a). …”
  7. 12547
  8. 12548
  9. 12549

    Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques by Vincent Munster (9399053)

    Published 2021
    “…Here, we studied the pathogenicity of variants of concern (VOC) B.1.1.7 and B.1.351 in rhesus macaques and compared it to a recent clade B.1 SARS-CoV-2 isolate containing the D614G substitution in spike. …”
  10. 12550
  11. 12551

    Image_5_Host autophagy limits Toxoplasma gondii proliferation in the absence of IFN-γ by affecting the hijack of Rab11A-positive vesicles.TIF by Lingtao Pan (9433257)

    Published 2022
    “…Further, after T. gondii infection, the abundance of Rab11A remained stable in wild-type HeLa cells but decreased in atg5<sup>−/−</sup> mutant. …”
  12. 12552
  13. 12553
  14. 12554
  15. 12555

    A Fractional Bond Order of 1/2 in Pd<sub>2</sub><sup>5+</sup>−Formamidinate Species; The Value of Very High-Field EPR Spectra by John F. Berry (1391989)

    Published 2007
    “…Reaction of Pd<sub>2</sub>(DAniF)<sub>4</sub>, <b>1</b>, (DAniF = di-<i>p</i>-anisylformamidinate) with 1 equiv of AgPF<sub>6</sub> in CH<sub>2</sub>Cl<sub>2</sub> at or below −10 °C produces the paramagnetic species [Pd<sub>2</sub>(DAniF)<sub>4</sub>]PF<sub>6</sub>, <b>1-PF</b><b><sub>6</sub></b>, that has been studied by X-ray crystallography, UV−vis spectroscopy, electrochemistry, and multifrequency (9.5, 34.5, 110, and 220 GHz) EPR spectroscopy. Upon oxidation of the precursor, the Pd−Pd distance decreases by 0.052 Å from 2.6486(8) to 2.597(1) Å. …”
  16. 12556

    Proteins identified by 2D-DIGE LC-MS/MS with differential abundance in CDR 1 vs. CDR 0 CSF. by Richard J. Perrin (224124)

    Published 2011
    “…</p><p>Column 4, name of protein identified by MASCOT.</p><p>Column 5, fold-change in protein abundance; negative values indicate decreases in CDR 1 vs. …”
  17. 12557

    Data_Sheet_1_Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models.docx by Aleksandar Janev (11024772)

    Published 2021
    “…This study aimed to investigate the anticancer activity of hAM homogenate on 2D and 3D cancer models. We evaluated the effects of hAM homogenates on the human muscle invasive bladder cancer urothelial (T24) cells, papillary cancer urothelial (RT4) cells and normal porcine urothelial (NPU) cells as well as on human mammary gland non-tumorigenic (MCF10a) cells and low-metastatic breast cancer (MCF7) cells. …”
  18. 12558
  19. 12559
  20. 12560